Jefferies Downgrades Replimune Group to Hold, Lowers Price Target to $2

Benzinga Newsdesk www.benzinga.com Negative 91.2%

Neg 91.2% Neu 0% Pos 0%

Jefferies analyst Roger Song downgrades Replimune Group (NASDAQ:REPL) from Buy to Hold and lowers the price target from $13 to $2.